Xeureka provides solutions for drug discovery research in the areas of both the Dry (computational) and Wet (experimental) drug discovery.
We will develop further value-added services in collaboration with external partners that can provide significant experimental technology capabilities.
Ultra Large Primary Screening
Utilizing a variety of domestic and overseas CRO partners, we can prepare compounds and conduct assays
to experimentally verify the biological activity of compounds identified by ultra-large scale virtual screening.
We evaluate the drug target and assess the feasibility of Virtual Screening, compound procurement, and assay availability for Wet Verification.
Virtual Library Preparation
Preparation of ultra large sized virtual compound libraries to meet customer needs (Wuxi, Enamine, ChemDiv, etc.)
High-Resolution Structure and Data Processing
・Structure-based (SB): The resolution of structural data can be improved, as needed.
・Ligand-based (LB): We collect and curate public data, combining it with proprietary customer data, to create an AI model
Virtual Screening (VS) Conducted
We conduct 3 levels of SBVS computation:
・Fast Screening (Active Learning)
LBVS is based on similarity searching using
an AI model with unbiased scoring.
Wet Synthesis and Verification
Hundreds to dozens of compounds are prepared and tested experimentally, with physical samples provided, as needed.